Developments in the law may jeopardize the validity of patents claiming monoclonal antibodies. This 90-minute webinar will help you understand the following:
- Guidance from the Federal Circuit on the current enablement and written description standards for claiming antibodies
- Strategies and pitfalls in claiming antibody-based compositions of matter
- Implications for method of treatment claims
- Steps every innovator should take before facing competition
View on-demand recording
For more information, please email Jess Karas.